Share

February 2014; 4 (1) Eye on Practice

Sleep medicine practice adaptations

Marc Raphaelson, Daniel B. Brown
First published February 17, 2014, DOI: https://doi.org/10.1212/01.CPJ.0000442522.30233.34
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
105

Share

Article Information

vol. 4 no. 1 63-70
DOI: 
https://doi.org/10.1212/01.CPJ.0000442522.30233.34
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • First Published February 17, 2014.
Copyright & Usage: 
© 2014 American Academy of Neurology

Author Disclosures

    1. Marc Raphaelson, MD, FAAN, FAASM and
    2. Daniel B. Brown, Esq
  1. Marc Raphaelson, MD, FAAN, FAASM and
    2. Scientific Advisory Boards:

    1. Jazz Pharmaceutical.

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Jazz Pharmaceutical.

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Marc Raphaelson, MD, PA, Inc. This practice collects fees from governmental and commercial insurers. President, 10 years.

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. Jazz Pharmaceutical.

    Other Activities:

    1. Medical director, northern Virginia, for SleepMed Inc. It is a for-profit entity providing sleep medicine testing and treatment.

    Clinical Procedures or Imaging Studies:

    1. Marc Raphaelson, MD, PA, Inc. This practice collects fees from governmental and commercial insurers. President, 10 years. The practice includes sleep studies, PSG, and patient management. I do not see a benefit to the practice if these advisories are followed by other practices.

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. Prepared affidavit for Sleep Information Systems, a for-profit entity now dissolved.

  2. Daniel B. Brown, Esq
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Fisher & Paykel Healthcare, Inc., Speaker Honoraria

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Sleeping Well, LLC Fisher & Paykel Healthcare, Inc.

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Dresevic, Gustafson, Iwrey, Kalmowitz and Pendleton, The Health Law Partners (DBB), Atlanta, GA.
  1. Correspondence to:
    raphaels4{at}aol.com
View Full Text

Article usage

Article usage: February 2014 to April 2022

AbstractFullPdfSource
Feb 20142582227Highwire
Mar 2014476112Highwire
Apr 201434026Highwire
May 201413700Highwire
Jun 201413972Highwire
Jul 20145901Highwire
Aug 20147422Highwire
Sep 20147001Highwire
Oct 20144400Highwire
Nov 20143931Highwire
Dec 20141660Highwire
Jan 20154002Highwire
Feb 20152300Highwire
Mar 20155600Highwire
Apr 20151002Highwire
May 20151002Highwire
Jun 20151100Highwire
Jul 20151001Highwire
Aug 20151000Highwire
Sep 20152101Highwire
Oct 20151700Highwire
Nov 20155703Highwire
Dec 20155200Highwire
Jan 20164800Highwire
Feb 20161601Highwire
Mar 20161700Highwire
Apr 2016600Highwire
May 20161100Highwire
Jun 2016600Highwire
Jul 2016600Highwire
Aug 2016800Highwire
Sep 20162600Highwire
Oct 20161900Highwire
Nov 20162700Highwire
Dec 20163200Highwire
Jan 20173100Highwire
Feb 20171300Highwire
Mar 20172700Highwire
Apr 2017800Highwire
May 20171501Highwire
Jun 20171010Highwire
Jul 2017500Highwire
Aug 2017500Highwire
Sep 2017500Highwire
Oct 20173200Highwire
Nov 20172600Highwire
Dec 20171210Highwire
Jan 20181412Highwire
Feb 20181600Highwire
Mar 20181400Highwire
Apr 2018910Highwire
Apr 2018045pmc
May 20182200Highwire
Jun 20181600Highwire
Jun 201821212pmc
Jul 20182100Highwire
Aug 20181600Highwire
Aug 201801111pmc
Sep 20181800Highwire
Oct 20183900Highwire
Nov 20182610Highwire
Dec 20185910Highwire
Jan 2019900Highwire
Feb 20191700Highwire
Mar 2019910Highwire
Apr 20191411Highwire
May 2019920Highwire
Jun 20191712Highwire
Jul 2019400Highwire
Aug 2019100Highwire
Sep 2019710Highwire
Oct 2019611Highwire
Nov 20191710Highwire
Dec 20192020Highwire
Jan 20201421Highwire
Feb 20201310Highwire
Mar 2020510Highwire
Apr 2020400Highwire
May 20201000Highwire
Jun 2020301Highwire
Jul 2020600Highwire
Aug 2020801Highwire
Sep 2020900Highwire
Oct 20202010Highwire
Nov 2020710Highwire
Dec 20202320Highwire
Jan 2021610Highwire
Feb 2021900Highwire
Mar 20211511Highwire
Apr 2021420Highwire
May 2021920Highwire
Jun 2021610Highwire
Jul 20211810Highwire
Aug 20213341Highwire
Sep 20211300Highwire
Oct 20211210Highwire
Nov 20211510Highwire
Dec 20211210Highwire
Jan 20221100Highwire
Feb 20222200Highwire
Mar 20222211Highwire
Apr 20221100Highwire

The Nerve!: Rapid online correspondence

Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me